Canadian Cancer Trials Group Bulletins


Update: Correction MA.37 activation announcement

Our last bulletin announced the activation of MA.37 indicating that interested sites should contact the study coordinator. Please note that Canadian participation in MA.37 is limited to 20 pre-selected and approved sites. If your site is not on the approved list, please contact the MA.37 CCTG study team for more information and to be placed on the wait list.

The Study Coordinator email for MA.37 is